ALLEN, Texas (PRWEB)
October 01, 2021

Newline Interactive is pleased to announce that its latest innovation, Newline Flex, has been recognized by Enterprise Connect. The Best of Enterprise Connect Awards Program recognizes excellence and innovation in the enterprise communications and collaboration industry. Judges vetted multiple entries with a focus on factors including technology advancement, innovation and business impact. The announcement came during the 2021 Enterprise Connect virtual conference.

Released December 2020, the Flex was a response to the overwhelming demand for more adaptable technology during the pandemic. It primarily serves as a touch interface for non-touch laptops and a unified communications device for virtual meetings. Boasting a 4K display, 4K camera, integrated mics and speaker, and an intuitive active pen—Flex is the ultimate remote/hybrid work companion.

“We have always strived to provide the best innovations to meet our customer’s demands,” said Chris Bradford, Newline President. “Flex has been a home run for all of our end users. The intentional product design really stepped up to the plate when it was needed most. Even in the Post-COVID workplace, it will continue to play a huge part.”

Newline Flex is in stock and available from Newline Interactive for purchase. Each unit comes with a modular 4K camera, active pen, USB-C connector cable, and power cable with adapter. Learn more about the desktop collaboration device at the Newline website.

###

About Newline Interactive

Headquartered in Allen, Texas, Newline Interactive is a leading supplier of interactive touch screens and innovative software that increases productivity and enables collaboration. Newline Interactive develops products that help organizations in a wide range of vertical markets including financial services, education, healthcare, law enforcement, manufacturing, municipalities, and legal services.

About Enterprise Connect

For more than 30 years, Enterprise Connect has been the leading conference and exhibition for enterprise communications and collaboration in North America. Enterprise Connect brings corporate IT decision makers together with the industry’s vendors, analysts and consultants to focus on the issues central to enterprise communications. Enterprise Connect owns and produces No Jitter, (nojitter.com), providing daily blogging and analysis of enterprise communications, and it also serves the community with a weekly email newsletter, research surveys and a Webinar Series. For more information, visit http://enterpriseconnect.com/orlando. Enterprise Connect is brought to you by Informa Tech.

Share article on social media or email:

All Calm Strips orders during the month of October will include the special TLC symbol Calm Strip, along with an information card about body-focused repetitive behaviors.

Raising awareness and support for people experiencing body-focused behaviors is personally important to me.

NEWPORT NEWS, Va. (PRWEB)
October 01, 2021

In partnership with the TLC Foundation for Body-focused Repetitive Behaviors, Calm Strips has developed the first-ever square shaped textured sensory adhesive to support BFRB (Body-focused Repetitive Behavior) Awareness Week 2021, October 1-7, 2021.

The reusable, residue-free adhesive highlights the TLC Foundation’s symbol, which is a stylized representation of repetitive behavior. The TLC Foundation’s symbol is intended to evoke feelings of inclusion, safety, security, support, healing, and connection – reminding individuals experiencing BFRBs that they are not alone.

“We are incredibly grateful to Calm Strips for their support of the 1-in-20 individuals diagnosed with a body-focused repetitive behavior, and the people who love and support them,” said Jen Monteleone, interim executive director of the TLC Foundation for BFRBs. “It’s our goal through BFRB Awareness Week to break down myths and misperception about BFRBs, that often leads to isolation and shame.”

In honor of BFRB Awareness Week, sales that use the code TLCBFRB20 from October 1-8, 2021 will receive a 20 percent discount with 10 percent of those sales donated back to the TLC Foundation for Body-focused Repetitive Behaviors.

“Raising awareness and support for people experiencing body-focused behaviors is personally important to me,” said Michael Malkin, creator and founder of Calm Strips. “We’re proud to be a part of an important week that celebrates this resilient community.”

All orders during the month of October will include the special TLC symbol Calm Strip, along with an information card about body-focused repetitive behaviors.

Calm Strips are available for purchase at: http://www.calmstrips.com

Contact:

Jessica Apicella

BuzzBright PR: jessica@buzzbrightpr.com

Share article on social media or email:

“We are excited to fund the first cohort of research studies under the CURE-19 collaboration with NYC Health + Hospitals,” said Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System.

NEW YORK (PRWEB)
October 01, 2021

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals today announced the four inaugural grant awardees of the CURE-19 Research Pilot Projects, an initiative to support collaborative, interdisciplinary COVID-19 research to better understand the novel virus that has transformed health care globally. Each winner will receive $25,000 to support their research project thanks to funding by Icahn Mount Sinai.

The CURE-19 Research Pilot Projects will support new COVID-19 research over the next five years, with an emphasis on projects related to disease control for large communities, informatics and decision support systems, addressing structural racism and social determinants of health, translational science research, and evidence-based interventions and policies. The projects will also address the long-term effects of COVID-19, social and environmental determinants of COVID-19, and maternal and child health related to COVID-19.

“Elmhurst is thrilled to collaborate with our colleagues at Mount Sinai to further understand the relationship between COVID-19 and community, clinical, and socio-economic variables,” said NYC Health + Hospitals/Elmhurst CEO Helen Arteaga Landaverde, MPH. “We saw first-hand how terribly impacted our precious community was in the early days and weeks of the pandemic. However, that impact will have lasting effects for decades and generations to come. It is critical, as community health care providers, to thoroughly understand these impacts and better adapt our care and support services to those needs.”

“Congratulations to the four inaugural grant awardees of the CURE-19 Research Pilot Projects,” said NYC Health + Hospitals/Queens CEO Neil J. Moore, MBA, MPA, FACHE. “By partnering with our neighboring health institutions, our experts will be able to collect larger samples of information to draw stronger conclusions and correlations that will ultimately help address health needs in these communities, now and in the future.”

“We are excited to fund the first cohort of research studies under the CURE-19 collaboration with NYC Health + Hospitals,” said Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “The pandemic has disproportionately affected vulnerable populations. We must understand the systemic issues in order to address inequities in medicine and provide equitable care that improves health outcomes and enhances pandemic preparedness and response initiatives.”

The inaugural research grant winners and their projects include:

1. Environmental Impact on Outcomes: Saadiyah Bilal, MD, MPH, Assistant Professor of Emergency Medicine at Icahn Mount Sinai, will examine the relationship between neighborhood-level community variables with clinical outcomes and vaccination rates for patients with COVID-19.

2. Community Health Care Workers: Stanley Pierre, MD, MPA, Patient Safety Coordinator and Director of the Clinical Centers of Excellence Development Program, NYC Health + Hospitals/Queens, will examine how community health care workers can promote equity in vaccine access and trust to historically marginalized and vulnerable communities.

3. Maternal COVID-19 Vaccination: Uday Patil, MD, Director of Neonatology and Newborn Services at NYC Health + Hospitals/Elmhurst, and Assistant Professor of Pediatrics, and Global Health and Health Systems Design, at Icahn Mount Sinai, will examine the transfer of passive immunity against COVID-19 to newborns after vaccination of mothers in diverse, multiethnic communities that are often underserved and underrepresented.

4. Opioid Overdose During Pandemic: Siri Shastry, MD, MS, Assistant Professor of Emergency Medicine at Icahn Mount Sinai, will examine the impact of COVID-19 on risk behaviors of patients with non-fatal opioid overdose in the Emergency Department, while understanding the influence of structural, community, and network factors.

The four inaugural research grant winners were required to submit a proposal that included a project summary or abstract, research description that emphasized its focus and significance, proposed timeline, list of principal and co-principal investigators, and more. The proposals were reviewed by a committee of research leaders from the CURE-19 partner institutions, who scored them on criteria including overall impact, significance, innovation, and approach.

The research pilot projects are part of a larger partnership known as the COVID-19 Unit for Research at NYC Health + Hospitals/Elmhurst and /Queens (CURE-19), a collaboration between Mount Sinai’s Arnhold Institute for Global Health and NYC Health + Hospitals/Elmhurst Global Health Institute that formed during the initial peak of the pandemic in 2020. CURE-19 translates data, experiences, and lessons from clinicians at the Mount Sinai Health System, NYC Health + Hospitals/Elmhurst, and NYC Health + Hospitals/Queens into research to address both the global pandemic and root causes of health disparities in New York City.

###

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 free-standing joint-venture centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked in U.S. News & World Report’s “Honor Roll” of the top 20 U.S. hospitals and among the top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Urology, and Rehabilitation. Mount Sinai Kravis Children’s Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked among the Top 20 nationally for ophthalmology. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report

“Honor Roll” Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and top five globally, and Mount Sinai Morningside as top 20 globally, and “The World’s Best Specialized Hospitals” ranks Mount Sinai Heart as No. 1 in New York and No. 5 globally and the Division of Gastroenterology as No. 5 globally. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

About NYC Health + Hospitals

NYC Health + Hospitals is the largest public health care system in the nation serving more than a million New Yorkers annually in more than 70 patient care locations across the city’s five boroughs. A robust network of outpatient, neighborhood-based primary and specialty care centers anchors care coordination with the system’s trauma centers, nursing homes, post-acute care centers, home care agency, and MetroPlus health plan – all supported by 11 essential hospitals. Its diverse workforce of more than 42,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest life possible. For more information, visit http://www.nychealthandhospitals.org and stay connected on Facebook at https://www.facebook.com/NYCHealthSystem/ or Twitter at @NYCHealthSystem.

Owner and founder of SteinLaw was named to the Outstanding Young Professionals of South Florida Top 40 Under 40 List

“I am honored to be recognized as one of the many outstanding young professionals in South Florida,” said Brandon Stein.

MIAMI (PRWEB)
October 01, 2021

Personal injury lawyer Brandon Stein, owner and founder of SteinLaw, was recently named to the Outstanding Young Professionals of South Florida Top 40 Under 40 List.

The Top 40 Under 40 Outstanding Young Professionals of South Florida event chairpersons are Michal Meiler, Esq. and Jorge “JD” Lorenzo, Esq. Chairperson Emeritus Marco Ferri, Esq. is also leading this year’s campaign.

The 40 South Florida area honorees were selected for their distinguished accomplishments in four industries: Legal, Business, Real Estate and Healthcare. Stein is one of just 10 lawyers named to this year’s list.

As a part of the Top 40 Under 40 class of 2021, Brandon Stein has committed to assisting with raising funds for the Cystic Fibrosis Foundation, the world’s leading organization in the search for a cure for cystic fibrosis, a rare and fatal genetic disease.

“I am honored to be recognized as one of the many outstanding young professionals in South Florida,” said Brandon Stein. “As a lawyer who chose to specialize in personal injury law simply because I wanted to help people, I wholly support the mission of the Cystic Fibrosis Foundation. Its efforts to help families affected by cystic fibrosis is admirable.”

The Cystic Fibrosis Foundation relies on support from individuals and corporations, as it receives no federal funding. Virtual fundraising for the Top 40 Under 40 campaign began September 9 and will conclude November 19, 2021. The top fundraiser will be determined at that time, and an invitation-only award ceremony for honorees and their guests will take place on January 13, 2022.

The Bethesda, Md.-based Cystic Fibrosis Foundation was founded in 1955 by parents of children with cystic fibrosis. The foundation has been recognized by the National Institutes of Health as a model of care for chronic disease. The foundation’s efforts in drug development over the past 30 years has doubled the life expectancy for those affected by cystic fibrosis.

Brandon Stein received his J.D. from St. Thomas University School of Law in Miami Gardens, Fl. He prides himself on providing quality and top-notch representation for those injured in accidents and other incidents, such as car accidents, drownings, shootings, wrongful death, and much more.

For more information about injury cases and how the SteinLaw team can help, please visit their website. To help raise funds for the Cystic Fibrosis Foundation, please consider donating here.

More About SteinLaw

The SteinLaw injury lawyers focus on helping accident victims who have been injured or hurt by someone else’s negligence or wrongful conduct. The firm helps victims and their loved ones across Florida and has offices located in Aventura, Ft. Myers, Miami, Tampa, West Palm Beach, Weston and Ft. Lauderdale.

For more information about SteinLaw, visit their website https://www.steinlaw.com/ or call (877) 783-4652.

Share article on social media or email:

WEST PALM BEACH, Fla. (PRWEB)
October 01, 2021

Paybotic is honored to attend NECANN’s New Jersey Cannabis Convention to be held in Atlantic City. Paybotic Executive Brian O’Connor, VP of Partner Relations, Mahlon James, Director of Strategic Initiatives, Tom Wondra, and Co-Founder and President, Max Miller will attend the convention on behalf of the national payment processing services provider. They will operate an exhibit at table 608 near the west entrance to the attendee lounge area.

Since 2014, NECANN has developed into a hub of knowledge and resources for cannabis entrepreneurs and enthusiasts throughout the industry and northeastern United States. The expo’s objective is to foster engagement, learning, and expansion for the potential of cannabis market opportunities among business owners, investors, academics, legal activists, and medical/retail consumers.

As a regionally-concentrated convention, NECANN’s goal to highlight the needs and potential of proximal cannabis markets creates an expo that results in opportunities for success greater than what national shows offer. Paybotic looks forward to showing cannabis business owners and key decision makers in areas such as New Jersey, Maryland, and Massachusetts how its payment processing technology helps dispensaries thrive in a high-risk industry with varying demands and regulation.

The first two days of the conference will begin at 11:00 and 10:00 a.m. respectively, with each featuring several workshops and seminars that run throughout the session concerning various commercial and recreational cannabis subjects. The final day — ending at 3:00 p.m. — will commence with a series of events that specifically target those in fields such as cultivation, production, environmental sustainability, higher education, consumer behavior, tourism, social justice, and more.

Vendors, guest speakers, and potential investors are welcome to attend and participate in the 2021 New Jersey Cannabis Convention. Please visit the event website for more information on hosting an exhibit, obtaining a press pass, acquiring tickets, or becoming a NECANN sponsor.

About Paybotic

Paybotic is one of the largest payment processing solution providers for high-risk merchants in the United States. The company specializes in helping cannabis-related businesses process customer payments and maintain compliance amid evolving regulation.

As innovators in the FinTech space, products such as the Cashless ATM have been obvious solutions for Paybotic to implement across the cannabis industry. The company actively works with a variety of sizes of businesses—from single store locations to multi-state operators and even publicly-traded companies.

Cannabis business owners or decision makers with interest in one or several of Paybotic’s full suite of industry payment processing services can call 844-420-4729 for more information. Those interested can also visit the Paybotic website to speak with a live agent.

Share article on social media or email:

“Our support and implementation are delivered by experts with over 275 years of experience in long-term care,” said Cassie Poier, the client services manager at Experience Care. “And they either deliver the answer themselves or work their contacts internally until one is found.”

AUSTIN, Texas (PRWEB)
October 01, 2021

A new report reveals that the business process outsourcing market size is expected to hit $405.8 billion by 2028. One provider of software to nursing homes, Experience Care, hopes to buck that trend in refusing to outsource its customer service.

Research shows that outsourcing jobs leads to both a decline in job quality and lower wages for Americans. And yet, more than two-thirds of businesses are doing so in order to help with the bottom line.

One small company, however, refuses to give in and employ foreigners who are willing to work for lower wages. “We’ve built meaningful relationships with our clients over the course of our 52-year history,” said Jason Long, the CEO of Texas-based Experience Care (http://www.experience.care). “And we know that our customer service is at the heart of who we are, not as a business but what I would call ‘a community’.”

Experience Care has dedicated client service representatives located throughout the U.S. working in all time zones, which means customers can speak to a real person from 5 A.M. Eastern to 8 P.M. Eastern. “Our support and implementation are delivered by experts with over 275 years of experience in long-term care,” said Cassie Poier, the client services manager at Experience Care. “And they either deliver the answer themselves or work their contacts internally until one is found.” Last summer, Experience Care added two clinical implementation and support specialists with over 20 years of experience in long-term care to its customer service team.

The long-term care EHR vendor knows that its users are faced with pressing concerns every day, as nursing homes must overcome COVID-19 outbreaks, staffing issues, and plummeting census numbers. It is for this reason that they are quick to respond to issues. “Our average response time for 2021 is 54 minutes,” said Poier. “Our service level agreement is 60 minutes for critical issues, under four hours for high priority issues, six to eight hours for medium priority, and by the next business day for low priority. And we hit those numbers one hundred percent of the time.” She added that the company has a log that is checked nightly to ensure all voicemails and emails are documented.

This quick turnaround stands in stark contrast to the response times of larger EHR providers, which may take days to respond or reserve customer support for clients who pay for the privilege to be in higher tiers. “If you don’t pay for the upper-tier you never hear back,” Poier said of some of Experience Care’s competitors. “But we don’t have tiered support here. Our clients and the value of what they do just mean too much to us.”

For more about the most recent developments at Experience Care, you can read their blog here: https://experience.care/blog/

About Experience Care LLC: Founded in 1969, Experience Care LLC is one of the largest providers of electronic health records, revenue cycle management, and financial systems to skilled nursing facilities, assisted living, continuing care retirement communities, long-term acute care, and other long-term care organizations in the U.S. Experience Care’s mission is to make every long-term care organization a fulfilling place to live and work by helping maximize financial success and compliance to achieve the best teams, care, and outcomes.

2/3 of jobs outsourced:

While outsourcing customer service results in greater profits for the highest earners, according to a recent study it usually means lower quality of work and lower wages; both customers and the average American worker lose.

Share article on social media or email:

David Zeman is the new Chief Strategy Officer for ENT and Allergy Associates, LLP.

David’s educational and professional backgrounds make him uniquely qualified to help us in the coming years as we develop and implement strategies to prepare for the future of health care.

TARRYTOWN, N.Y. (PRWEB)
October 01, 2021

ENT and Allergy Associates, LLP has experienced a tremendous era of growth and expansion in recent years to become the largest ear, nose, throat, allergy, and audiology practice in the country. In order to maintain this progression, ENTA announced today it has expanded and strengthened its management team by hiring David Zeman as its new Chief Strategy Officer.

Mr. Zeman will begin his functions as new CSO effective November 1, 2021.

The expansion of the ENTA management team is a direct response to the forecasted business growth going into the next decade. In this role, Mr. Zeman will report directly to ENTA’s Chief Executive Officer, Robert Glazer.

Mr. Zeman will be responsible for regional strategic growth through mergers, acquisitions, joint ventures and creative partnerships with health systems, hospitals, and physicians. He will oversee strategic planning and monitoring, new business planning and development, marketing and physician relations initiatives, managed care contracting, and marketplace trends.

Mr. Zeman most recently served as Vice President of Regional Markets for the Hospital for Special Surgery (HSS), where he led the administration of outpatient programming within the Tri-State area, including direct day-to-day operations of seven outpatient centers consisting of physician office activity, advanced imaging, and physical therapy. He also oversaw the growth of Regional Market programming with direct responsibility of new facility expansion, including strategic market development, clinical, administrative, and financial programming, and facility design.

Prior to HSS, Mr. Zeman was the Senior Administrative Director at Northwell Health’s Lenox Hill Hospital-MEETH, Department of Otolaryngology-Head & Neck Surgery, where he led and directed the administrative functions for inpatient and ambulatory activity of the Department of Otolaryngology-Head and Neck Surgery and oversaw activities including growth objectives, space allocation, procurement of technological equipment, data planning, goal development, capital planning, and human resources.

Mr. Zeman earned his M.B.A. in Healthcare Administration from Baruch College’s Zicklin School of Business/Icahn School of Medicine at Mount Sinai, and his B.A. in Political Science from Washington University in St. Louis.

“David was the best fit from a pool of great candidates during our extensive search,” said Robert Glazer, CEO of ENTA. “His educational and professional backgrounds make him uniquely qualified to help us in the coming years as we develop and implement strategies to prepare for the future of health care.”

“I am very excited to be joining the ENTA team,” said David Zeman. “I believe ENTA has a great business model and talented management team. The group is uniquely positioned to capitalize on the changing healthcare environment, and I look forward to building relationships and services that allow ENTA to provide world-class healthcare to patients close to home.”

For more information about ENT and Allergy Associates, or to book your same-day appointment, please visit http://www.entandallergy.com.

About ENT and Allergy Associates, LLP:

ENT and Allergy Associates LLP (ENTA) has more than 220 physicians practicing in 44 office locations in Westchester, Putnam, Orange, Dutchess, Rockland, Nassau, and Suffolk counties, as well as New York City and northern/central New Jersey. The practice sees over 90,000 patients per month. Each ENTA clinical location provides access to a full complement of services, including General Adult and Pediatric ENT and Allergy, Voice and Swallowing, Advanced Sinus and Skull Base Surgery, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, Sleep and CT Services. ENTA has clinical alliances with Mount Sinai Hospital, Montefiore Medical Center, Northwell Health, and a partnership with the American Cancer Society.

Share article on social media or email: